Recent research conducted by teams led by Prof. Resia Pretorius and Dr. Alain Thierry has advanced the understanding of Long COVID by investigating the interaction between microclots and neutrophil extracellular traps (NETs). Microclots, introduced to the scientific discourse in 2021, are abnormal clumps of blood clotting proteins observed in COVID-19 patients. NETs are formed when neutrophils release their DNA during a process called NETosis, creating structures that can trap pathogens but may also contribute to harmful inflammation and clotting.
The researchers employed advanced imaging techniques and machine learning tools to analyze blood samples from Long COVID patients compared to healthy controls. Their findings indicated a significant increase in biomarkers associated with both microclots and NETs in patients with Long COVID. Notably, they discovered a structural relationship between the two, suggesting that dysregulated interactions could lead to pathogenic effects. This relationship was particularly pronounced in Long COVID patients, who exhibited larger and more abundant microclots.
The study highlights how excessive NET formation may stabilize microclots, making them more resistant to breakdown and potentially leading to chronic complications in the microvasculature. The use of artificial intelligence in the analysis allowed for improved differentiation between Long COVID patients and healthy individuals, paving the way for more precise diagnostics and personalized treatment approaches.
Overall, the research contributes valuable insights into the biological processes underlying Long COVID and emphasizes the need for targeted therapeutic strategies to address the associated thrombo-inflammatory responses. Additionally, it underscores the potential for identifying new biomarkers that could aid in the diagnosis and management of Long COVID, marking a significant step forward in understanding post-viral syndromes.